Gastroesophageal reflux disease (GERD) has a worldwide prevalence of 8–33%, involving
both sexes and all age groups. Based on the Montreal consensus definition, GERD is the …

Purpose: The diagnosis of gastroesophageal reflux (GERD) remains problematic. The
sensitivity and specificity of an empiric PPI trial is modest and most patients (Pts) with reflux …

Gastroesophagel reflux disease (GERD) is a common condition encountered in clinical
practice. Over the years there has been a continuous interaction between the understanding …

Gastro-esophageal reflux disease (GERD) occurs in about 25% of the general population.
The complexity of the disease and the multiplicity of its clinical manifestations impair the …

In the era of abundant and often overutilized acid suppressive therapy, primary care
physicians, gastroenterologists, and other specialists increasingly share a group of patients …

Purpose: The diagnosis of gastroesophageal reflux (GERD) remains problematic. Older
questionnaires have suffered from low sensitivity/specificity and lack of comparison with pH …

Diagnostic testing for GERD has evolved to include multi esophageal sites (distal, proximal
and hypopharyngeal monitoring), wireless pH, and oropharyngeal devices. The versatility of …

Gastroesophageal reflux disease (GERD) is a condition that develops when the reflux of
stomach contents causes troublesome symptoms and/or complications. Although proton …

OBJECTIVES: The gastroesophageal reflux disease questionnaire (GerdQ) is a validated
questionnaire that identifies patients with gastroesophageal reflux disease (GERD). The aim …

Center for Gastroenterological Research, Catholic University of Leuven, Leuven, Belgium
tion of patients with GERD symptoms, including typical symptoms in patients off PPIs …